{
    "2020-07-15": [
        [
            {
                "time": "",
                "original_text": "解盘：资金流出，科技股领跌，创新药、白酒略涨",
                "features": {
                    "keywords": [
                        "资金流出",
                        "科技股",
                        "领跌",
                        "创新药",
                        "白酒"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "科技",
                        "医药",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "智飞生物、爱尔眼科、康泰生物、沃森生物集体大涨并创新高，力撑创业板指",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "爱尔眼科",
                        "康泰生物",
                        "沃森生物",
                        "大涨",
                        "创新高",
                        "创业板指"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "沃森生物上半年净利预降近三成：新冠疫苗等项目研发费用增加 盈利能力下降",
                "features": {
                    "keywords": [
                        "沃森生物",
                        "净利预降",
                        "新冠疫苗",
                        "研发费用",
                        "盈利能力下降"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}